Skip to content

Analysing the blood Methyl Malonic Acid and blood Vitamin B12 levels in patients with mouth early stage cancers

Evaluation of Serum Methyl Malonic acid and Vitamin B12 status in patients with Oral Potentially Malignant Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/08/044847
Enrollment
52
Registered
2022-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

None listed

Sponsors

Rajiv Gandhi University of Health Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The study consists of 2 groups within the age range of 20 to 60 years. Group A: 26 subjects of Oral Potentially Malignant Disorders Group B: 26 subjects of healthy controls Patients will be informed about the study and consent will be obtained. The subjects will be collected by Simple random sampling method. Subjects will be diagnosed clinically and confirmed histopathologically as oral potentially malignant disorders will be considered as cases.

Exclusion criteria

Exclusion criteria: Patients with history of Renal diseases, hematological disorders, liver diseases, gastrointestinal disorders, nutritional deficiencies, prior medication of external supplements and pregnancy will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
To obtain a reliable biomarker Serum Methyl Malonic Acid in Oral Potentially Malignant Disorders and to coorelate the marker with serum Vitamin B12 and the stages of progression of the Oral Potentially Malignant disorderTimepoint: To obtain a reliable biomarker Serum Methyl Malonic Acid in Oral Potentially Malignant Disorders in first 6 months and to coorelate the marker with serum Vitamin B12 and the stages of progression of the Oral Potentially Malignant disorder in the next 6 months.

Secondary

MeasureTime frame
The levels of METHYL Malonic Acid may vary in different stages of Oral Potentially Malignant Disorders and in different lesionsTimepoint: 2 years

Countries

India

Contacts

Public ContactDurga Rajaram Okade

Sri Rajiv Gandhi College of Dental Sciences and hospital

hrishidurga@gmail.com9632680474

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026